Kratom pharmacology: Clues from planarians exposed to mitragynine

被引:1
|
作者
Uddin, Sarah [1 ]
Wiah, Sonita [1 ]
Kim, Tony [1 ]
Watson, Mia N. [1 ]
Jennings, Tyra [1 ]
Rawls, Scott M. [1 ,2 ]
机构
[1] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
[2] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, 3500 North Broad St, Philadelphia, PA 19140 USA
基金
美国国家卫生研究院;
关键词
Mitragynine; Kratom; Opioid; Planarian; Invertebrate; Place preference; Dependence; ABSTINENCE-INDUCED WITHDRAWAL; CONDITIONED PLACE PREFERENCE; COCAINE; BEHAVIOR; SPECIOSA; EXPRESSION; NEUROPHARMACOLOGY; ACQUISITION; MEPHEDRONE;
D O I
10.1016/j.physbeh.2021.113499
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Mitragynine (MG), the most prevalent bioactive alkaloid in kratom, displays nanomolar affinity for mu, kappa and delta opioid receptors and produces opioid-dependent antinociception and dependence in rats. Here, using a battery of behavioral assays, we investigated MG effects in planarians. Acute MG exposure (< 100 mu M) did not affect planarian motility or environmental preference, but reduced motility was detected during abstinence from chronic MG (1, 10 mu M). MG (10 mu M) produced place conditioning effects that were reduced by naltrexone (10 mu\M). These results suggest that MG produces opioid-sensitive reinforcing effects in planarians and MG pharmacology is conserved across different species.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Nicotine behavioral pharmacology: Clues from planarians
    Rawls, Scott M.
    Patil, Tanvi
    Tallarida, Christopher S.
    Baron, Steven
    Kim, Myongji
    Song, Kevin
    Ward, Sara
    Raffa, Robert B.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2011, 118 (2-3) : 274 - 279
  • [2] Extraction of an active component (mitragynine) from Kratom leaves
    Tran, Long
    Ng, Karno
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] PSYCHOACTIVE PROPERTIES OF MITRAGYNINE (KRATOM)
    JANSEN, KLR
    PRAST, CJ
    [J]. JOURNAL OF PSYCHOACTIVE DRUGS, 1988, 20 (04) : 455 - 457
  • [4] Pharmacokinetic study of mitragynine in Kratom abuse
    Trakulsrichai, Satariya
    Sathirakul, Kobthum
    Auparakkitanon, Saranya
    Krongvorakul, Jatupon
    Sueajai, Jetjamnong
    Noumjad, Nantida
    Wananukul, Winai
    [J]. CLINICAL TOXICOLOGY, 2014, 52 (04) : 396 - 396
  • [5] Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy
    Papsun, Donna
    Schroeder II, William
    Brower, Justin
    Logan, Barry
    [J]. CURRENT ADDICTION REPORTS, 2023, 10 (02) : 272 - 281
  • [6] Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy
    Donna Papsun
    William Schroeder
    Justin Brower
    Barry Logan
    [J]. Current Addiction Reports, 2023, 10 : 272 - 281
  • [7] Mitragynine (Kratom) - monitoring in sports drug testing
    Guddat, Sven
    Goergens, Christian
    Steinhart, Vanessa
    Schaenzer, Wilhelm
    Thevis, Mario
    [J]. DRUG TESTING AND ANALYSIS, 2016, 8 (11-12) : 1114 - 1118
  • [8] Sodium nitroprusside triggers mitragynine biosynthesis in Kratom
    Wungsintaweekul, J.
    Perstwong, N.
    Limsuwanchote, S.
    Keawpradub, N.
    [J]. PLANTA MEDICA, 2019, 85 (18) : 1450 - 1451
  • [9] Drying Characteristics and Mitragynine Content of Kratom Leaves
    Chungsiriporn, Juntima
    Pongyeela, Prukraya
    Chairerk, Nirana
    Iewkittayakorn, Jutarut
    Duangsuwan, Wiriya
    [J]. CHIANG MAI JOURNAL OF SCIENCE, 2023, 50 (06):
  • [10] Neurobiology of Kratom and its main alkaloid mitragynine
    Suhaimi, Farah W.
    Yusoff, Nurul H. M.
    Hassan, Rahimah
    Mansor, Sharif M.
    Navaratnam, Visweswaran
    Mueller, Christian P.
    Hassan, Zurina
    [J]. BRAIN RESEARCH BULLETIN, 2016, 126 : 29 - 40